Physician profile
Andrew J Friedmann
NPI 1467899229
$25,864.49
in general payments reported to CMS, 2019-2025
22 companies · $724 in 2025
The $724 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,532 · 2021: $464 · 2022: $2,212 · 2023: $2,235 · 2024: $1,299 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,974 · Travel and Lodging: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,974.32 |
| Travel and Lodging | $1,283.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $16,089.23 | 2019-2023 | |
| Medinc of Texas | $3,838.60 | 2019-2025 | |
| Stryker Corporation | $2,627.01 | 2019-2025 | Citrefix, Augment Injectable, Variax |
| Wright Medical Technology, INC. | $1,372.78 | 2019-2020 | |
| Medshape, INC. | $371.50 | 2022 | |
| Heron Therapeutics, INC. | $301.24 | 2024-2025 | Zynrelef |
| Paragon 28, INC. | $199.59 | 2019-2021 | |
| Exactech, INC. | $178.10 | 2024 | |
| In2bones USA, LLC | $176.58 | 2021-2022 | |
| Treace Medical Concepts, INC. | $142.88 | 2023 | |
| Forma Medical | $140.33 | 2025 | Optimalmtp |
| Depuy Synthes Sales INC. | $137.60 | 2019-2023 | Orthovisc, Monovisc |
| Ossur Americas, INC. | $75.00 | 2024 | |
| Alafair Biosciences, INC. | $49.05 | 2025 | Versawrap |
| Tricoast Surgical Solutions LLC | $42.42 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $22.63 | 2022 | |
| Kci USA, INC. | $21.47 | 2023 | Prevena |
| Innovation Technologies INC | $17.28 | 2022 | |
| Kerecis Limited | $16.58 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Horizon Therapeutics Plc | $15.86 | 2020 | |
| Ermi LLC | $15.19 | 2021 | |
| Bioventus LLC | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Friedmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.